Max Robotics — Global Service Robot Directory + US Certification

About

Hyun Koo is a pioneering researcher at the intersection of biofilm microbiology, nanotechnology, and small-scale robotics, whose work is reshaping how scientists and clinicians approach the treatment of persistent microbial infections. Best known for developing catalytic antimicrobial robots — a landmark 2019 study that has garnered over 270 citations — Koo has demonstrated that magnetically driven robotic systems can precisely and effectively eradicate bacterial biofilms, long considered one of medicine's most stubborn challenges. His laboratory has expanded this vision to address the full complexity of infection biology, engineering surface-adaptive robotic superstructures capable of navigating the irregular topography of human teeth, and developing nanozyme-based robotic platforms to combat high-priority fungal pathogens identified by the World Health Organization. Beyond treatment, Koo's group has pioneered microrobotic approaches to biofilm diagnostics, enabling simultaneous pathogen detection and targeted therapy with remarkable precision. His more recent work on adaptive microcapsule assemblies and applications in endodontics signals a broadening clinical horizon for these technologies. With hundreds of citations across multiple high-impact studies, Koo stands as a transformative figure whose interdisciplinary innovations are charting the future of infection control and precision medicine.